Cargando…

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD

The two main subsets of nonalcoholic fatty liver disease (NAFLD) include: (1) nonalcoholic fatty liver (NAFL), the more common and non-progressive subtype; and (2) nonalcoholic steatohepatitis (NASH), the less common subtype, which has the potential to progress to advanced liver damage. Current trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dibba, Pratima, Li, Andrew A., Perumpail, Brandon J., John, Nimy, Sallam, Sandy, Shah, Neha D., Kwong, Waiyee, Cholankeril, George, Kim, Donghee, Ahmed, Aijaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164020/ https://www.ncbi.nlm.nih.gov/pubmed/30235807 http://dx.doi.org/10.3390/diseases6030083

Ejemplares similares

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2019)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
por: Iqbal, Umair, et al.
Publicado: (2018)

The Role of Vitamin E in the Treatment of NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

When to Initiate Weight Loss Medications in the NAFLD Population
por: Yoo, Eric R., et al.
Publicado: (2018)

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD
por: Cholankeril, Rosann, et al.
Publicado: (2018)

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation
por: Li, Andrew A., et al.
Publicado: (2018)

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018)

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary
por: Dibba, Pratima, et al.
Publicado: (2019)

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
por: Perumpail, Brandon J., et al.
Publicado: (2017)

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
por: Perumpail, Brandon J, et al.
Publicado: (2017)

The Role of Cannabinoids in the Setting of Cirrhosis
por: Dibba, Pratima, et al.
Publicado: (2018)

Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis
por: Perumpail, Brandon J., et al.
Publicado: (2017)

The importance of a multidisciplinary approach to hepatocellular carcinoma
por: Siddique, Osama, et al.
Publicado: (2017)

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
por: Yoo, Eric R., et al.
Publicado: (2016)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
por: Iqbal, Umair, et al.
Publicado: (2019)

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents
por: Cholankeril, George, et al.
Publicado: (2017)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals
por: Yoo, Eric R., et al.
Publicado: (2017)

Hepatitis C in Pregnancy
por: Dibba, Pratima, et al.
Publicado: (2018)

Hepatic encephalopathy: what the multidisciplinary team can do
por: Liu, Andy, et al.
Publicado: (2017)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
por: Kim, Donghee, et al.
Publicado: (2021)

Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States
por: Kim, Donghee, et al.
Publicado: (2022)

Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality
por: Kim, Donghee, et al.
Publicado: (2023)

Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease
por: Cholankeril, George, et al.
Publicado: (2017)

Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience
por: Aggarwal, Avin, et al.
Publicado: (2017)

Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States
por: Kim, Donghee, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft
por: Liu, Andy, et al.
Publicado: (2018)

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States
por: Siddique, Osama, et al.
Publicado: (2017)

Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era
por: Li, Andrew A., et al.
Publicado: (2018)

NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2020)

Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher
por: Perumpail, Ryan B., et al.
Publicado: (2016)

High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California
por: Cholankeril, George, et al.
Publicado: (2020)

Tu1268: LONGITUDINAL ASSESSMENT OF SEROLOGICAL RESPONSE AFTER THREE DOSES OF SARS-COV-2 MRNA VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Gandle, Cassandra, et al.
Publicado: (2022)

Nutritional Needs and Support for Children with Chronic Liver Disease
por: Yang, Christine H., et al.
Publicado: (2017)

Su1373: UTILIZATION OF DRUG OVERDOSE DONORS FOR LIVER TRANSPLANTATION DURING COVID-19 PANDEMIC
por: Lymberopoulos, Peter, et al.
Publicado: (2022)

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation
por: Cholankeril, George, et al.
Publicado: (2019)

Implementation and Impact of Universal Preprocedure Testing of Patients for COVID-19 Before Endoscopy
por: Podboy, Alexander, et al.
Publicado: (2020)

Recent Epidemiology of Nonalcoholic Fatty Liver Disease
por: Murag, Soumya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i52ebmvnehvsse2bkbhre2fpse